Literature DB >> 23006018

The lived experience of ovarian cancer: a phenomenological approach.

Joanna Guenther1, Anne Stiles, Jane Dimmitt Champion.   

Abstract

PURPOSE: To describe the lived experience of women diagnosed with ovarian cancer using individual interviews. DATA SOURCES: Eleven women who had been diagnosed with ovarian cancer within the past five years were interviewed with open-ended guiding questions. The narrative responses were analyzed for constitutive patterns and relational themes according to Diekelmann and Allen's hermeneutic phenomenological process.
CONCLUSIONS: This phenomenological study gave voice to the women's experience with ovarian cancer. The following six constitutive patterns and associated themes emerged: (a) The Revelation, (b) Jeopardy, (c) On the Lookout, (d) Becoming Normal, and (e) Living Every Moment. IMPLICATIONS FOR PRACTICE: An understanding of the common experiences and shared meanings of women with ovarian cancer may contribute to earlier diagnosis and improved quality of life. The women identified symptoms that should generate concern when reported to providers, potentially leading to diagnostic testing. The experiences may also serve to inform the development of interventions aimed at meeting the needs of women diagnosed with ovarian cancer. ©2012 The Author(s) Journal compilation ©2012 American Academy of Nurse Practitioners.

Entities:  

Mesh:

Year:  2012        PMID: 23006018     DOI: 10.1111/j.1745-7599.2012.00732.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  2 in total

1.  Presence of gastro-intestinal symptoms in ovarian cancer patients during survivorship: a cross-sectional study from the PROFILES registry.

Authors:  Mark J A Rietveld; Olga Husson; M C Caroline Vos; Lonneke V van de Poll-Franse; P B Nelleke Ottevanger; Nicole P M Ezendam
Journal:  Support Care Cancer       Date:  2018-10-17       Impact factor: 3.603

2.  Vitamin D and DDX4 regulate the proliferation and invasion of ovarian cancer cells.

Authors:  Youguo Chen; Ziqian Sun; Jingbo Xu; Peifang Wang; Juan Tang; Xiaorui Shi; Jingjing Liu; Fangfang Ren; Lan Xu
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.